Graphite Bio stockholders elect three Class I directors and ratify auditor at 2022 Annual Meeting

LENZ Therapeutics, Inc.

Stockholders elected Jerel Davis, Perry Karsen, and Joseph Jimenez as Class I directors; each received >37M votes for, ~3M withheld.
Ratification of Deloitte & Touche as independent auditor for FY2022 passed with ~42.2M for, 5,230 against, 9,929 abstentions.
Total shares present or represented: 42,241,989 out of 57,970,110 shares entitled to vote.
Broker non-votes: 1,680,515 on director election; none on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.